• Tidak ada hasil yang ditemukan

Table S1: Characteristics of Resorbable Plating Systems

N/A
N/A
Protected

Academic year: 2024

Membagikan "Table S1: Characteristics of Resorbable Plating Systems"

Copied!
3
0
0

Teks penuh

(1)

Table S1: Characteristics of Resorbable Plating Systems

System Composition Reabsorption Time

Biomet LactoSorb 82% Poly-L-Lactic Acid and 18% Poly-Glycolic

Acid 12 months

Inion CPS Baby System L-Lactide, D,L-Lactide, Polyglycolide and

Trimethylene Carbonate (TMC) 24-36 months

Stryker Delta 85% Poly L-Lactide, 10% Poly-Glycolide, and 5%

Poly D-Lactide 8-13 months

KLS Martin SonicWeld Rx Amorphous poly-(50%D, 50%L)-lactide 12-30 months PDS suture Polydioxanone suture/poly(p-diaxanone) <2 months

(2)

Table S2: Patient and surgical characteristics, stratified by plating system.

Overall

202 (100%) Biomet Lactosorb

120 (59%) Other systems 82 (41%) Patient characteristics

Male, n (%) 123 (61) 70 (58) 53 (65)

Age, in days, median (IQR) 383 (227–802) 434 (230–967) 325 (214–595)

White, n (%) 119 (59) 71 (59) 48 (59)

Synostosis diagnosis, n (%)

Metopic 75 (37) 44 (37) 31 (38)

Coronal 42 (21) 26 (22) 16 (20)

Sagittal 71 (35) 45 (38) 26 (32)

Lambdoid 5 (2) 2 (2) 3 (4)

Multiple 23 (11) 14 (12) 9 (11)

Syndrome, n (%)

Apert 3 (1) 1 (1) 2 (2)

Beare-Stevenson 1 (1) 0 (0) 1 (1)

Catel Manzke 1 (1) 0 (0) 1 (1)

Cerebral palsy 4 (2) 3 (3) 1 (1)

Chromosomal abnormality 3 (1) 3 (3) 0 (0)

Cornelia de Lange 1 (1) 1 (1) 0 (0)

Crouzon 2 (1) 2 (0) 0 (0)

Muenke 3 (1) 1 (1) 2 (2)

Opitz G/BBB 1 (1) 0 (0) 1 (1)

Pfeiffer 2 (1) 1 (1) 1 (1)

Saethre-Chotzen 2 (1) 2 (2) 0 (0)

Turner 1 (1) 0 (0) 1 (1)

Other 15 (7) 9 (8) 6 (7)

Nonsyndromic, n (%) 163 (81) 97 (81) 66 (80)

Surgical characteristics Surgery type, n (%)

Cranial vault reconstruction 89 (44) 46 (38) 43 (53) Frontal orbital advancement 112 (56) 74 (62) 38 (47) Plating system, n (%)

Biomet 120 (59) 120 (100) --

Delta 26 (13) -- 26 (32)

PDS 33 (16) -- 33 (40)

Inion 12 (6) -- 12 (15)

KLS Martin 11 (5) -- 11 (13)

Abbreviations: IQR, interquartile range

(3)

Table S3: Crude and adjusted association between Biomet Lactosorb, compared to other plating systems, on 1-year incidence of wound complications.

Rate, per

10,000 days Crude Adjusteda

HR (95% CI) p-value HR (95% CI) p-value Biomet Lactosorb 8.5 2.27 (1.03, 5.00) 0.04 2.86 (1.15, 7.11) 0.02

Other systems 3.7 ref -- ref --

Abbreviations: HR, hazard ratio; CI, confidence interval

a Adjusted for year of surgery, patient age, in days, and surgery type; age was modeled as a restricted cubic spline

Referensi

Dokumen terkait